Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
NexOptic Begins Announcing New Team Additions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MindBio Therapeutics Corp. C.MBIO

Healthcare Biotechnology
MindBio Therapeutics Corp is a pioneering clinical stage biotechnology company that specializes in developing psychedelic microdosing treatments for mental health conditions. MindBio has obtained government and regulatory approvals for at-home LSD microdosing in clinical trials, making it the only organization in the world to do so.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:MBIO)

MindBio Therapeutics Team Members Honoured with Industry Leading Awards

Accesswire November 21, 2023

MindBio Therapeutics CEO Presents World First Phase 2B Take-Home Microdosing Clinical Trial in Cancer Patients

Accesswire October 31, 2023

MindBio Therapeutics Begins Dosing MB22001 in World First Phase 2B Microdosing Clinical Trial In Advanced Stage Cancer Patients

Accesswire October 28, 2023

Mindbio Therapeutics Nominated for Company of the Year in Industry Awards

Accesswire October 26, 2023

MindBio Therapeutics CEO Provides Video Update on Phase 2a Depression Trial Using MB22001

Accesswire October 24, 2023

Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials

Accesswire October 5, 2023

Mindbio Therapeutics CEO Provides Update on Depression Trial & Novel Discoveries in Psychedelics Research

Accesswire September 14, 2023

MindBio announces major genetic discovery in microdosing research

Jonathon Brown September 5, 2023

MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research

Accesswire September 5, 2023
View More News ››

Opinion & Analysis (CSE:MBIO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:MBIO)

This shows the BS of stocks, if you don't know how to look:

TSE says one trade, when it was actually 8 trades: so we actually closed at 3 cents. Watch ahole tomorrow, just going to sell their 3000...
Dude51 - November 14, 2023

Just some more news on the coming revolution in this space:

the "Psychedelic-Assisted Mental Health Care" https://www.marijuanamoment.net/first-ever-congressional-hearing-on-psychedelic...
Dude51 - November 11, 2023

More Good News for this stock:

https://www.stockwatch.com/News/Item/Z-C!MBIO-3470208/C/MBIO GL
Dude51 - October 27, 2023

Definitely a Startup…..

....but so much potential. The following is some background on the lead investigator for MindBio: https://profiles.auckland.ac.nz/sd...
Smokey1958 - October 26, 2023

If what Mind Bio is offering-micro dose LI- works fantastic

A person close to me has suffered chronic severe depression for almost 20 years. There are meds for downside feelings but there is...
Goodtoreadthis1 - October 26, 2023

Ahole still selling trying to manipulate:

So the buyers are looking to purchase 188 thousand shares. What do they know that Ahole doesn't? Ahole just fricken shaking the tree....
Dude51 - October 17, 2023
View more Bullboard ››

Canada Jetlines Operations Ltd

Canada Jetlines Operations Ltd

Canada Jetlines Operations Ltd. is a Canada-based leisure-focused air carrier. The Company's principal business activity is ...
View More »